Darrin Stuart, Ph.D.

Dr. Stuart has served as Scorpion Therapeutics’ Chief Scientific Officer since April 2020. Prior to joining the company, Dr. Stuart was Executive Director of Cancer Biology and Drug Discovery at Novartis Institutes for Biomedical Research (“Novartis”) between 2019 and 2020 and served in various other leadership roles at Novartis between 2006 and 2019. Dr. Stuart joined Novartis through the acquisition of Chiron Corporation where he held roles of increasing responsibility between 2000 and 2006.

Dr. Stuart holds Master’s and Bachelor’s Degrees in Biology from the University of Waterloo and earned his Ph.D. in Pharmacology from the University of Alberta.